Filing Flows

Filing Flows › Industries › Health Care › Medicinal Chemicals & Botanical Products

Medicinal Chemicals & Botanical Products SIC 2833

22 companies filing with the SEC under SIC 2833. Median revenue growth +5% year on year in Q2 2026 (middle half -5% to +22%, 22 companies). The growth model expects the industry's combined revenue to grow +10% in Q3 2026.

Companies22
Median growth Y/Y+5%
Middle half-5% to +22%
Industry revenue, next quarter+10% Y/Y (Q3 2026, model)
Medicinal Chemicals & Botanical Products: the largest companies by quarterly revenueMedicinal Chemicals & Botanical Products: the largest companies by quarterly revenueCURLF$353MTLRY$257MTRLV$230MUSNA$223MAAWH$126MCRON$83.9MJUSH$70.5MCGC$51.1MBTMD$43.3MMRMD$41.9MNAII$34.5MNAGE$27.2M
Medicinal Chemicals & Botanical Products: how many companies grew how fast (revenue, year over year)Medicinal Chemicals & Botanical Products: how many companies grew how fast (revenue, year over year)2< −25%2−25 to −10%4−10 to 0%60 to 10%210 to 25%225 to 50%4> 50%
Medicinal Chemicals & Botanical Products: the growth model's forecast of industry revenueMedicinal Chemicals & Botanical Products: the growth model's forecast of industry revenue80% rangemodel's central forecastQ3 2026$1.4BQ4 2026$1.4BQ1 2027$1.4BQ2 2027$1.5B

Money flow: where the industry's revenue goes

Drawn in the browser: an estimate of where the industry's revenue goes — what it buys from other industries, the pay that reaches households, taxes and profit — beside its filed cash flow, two tiers of suppliers and its capital spending by kind of asset.

Open the industry: growth distribution, money flow, network →

Growth model

Industry revenue, the same companies year on year; 80% ranges. Fitted on SEC filings and tested out of sample (how).

QuarterGrowth Y/YRevenue80% range
Q3 2026+9.9%$1.4B$1.2B – $1.5B
Q4 2026+12.9%$1.4B$1.3B – $1.6B
Q1 2027+14.4%$1.4B$1.3B – $1.6B
Q2 2027+14.9%$1.5B$1.4B – $1.7B

Capital spending and supply chain →

Companies

CompanyQuarterly revenueY/YStage
CURLF Curaleaf Holdings$353M+10%mature
TLRY Tilray Brands$257M+25%expansion
TRLV Trulieve Cannabis$230M-10%contraction
USNA Usana Health Sciences$223M-5%contraction
AAWH Ascend Wellness Holdings$126M-0.9%mature
CRON Cronos Group$83.9M+60%expansion
JUSH Jushi Holdings$70.5M+10%mature
CGC Canopy Growth$51.1M+13%transition
BTMD biote$43.3M-9%contraction
MRMD Marimed$41.9M+6%mature
NAII Natural Alternatives International$34.5M+2%deceleration
NAGE Niagen Bioscience$27.2M-4%mature
MTEX Mannatech$26.6M+4%mature
FTLF Fitlife Brands$26.5M+65%expansion
LEEEF Leef Brands$7.3M-16%contraction
CHUC Charlie's Holdings$3.8M+49%deceleration
HYEX Healthy Extracts$2.1M+113%expansion
MEHA Functional Brands$1.9M+2%mature
CBDY Target Group$1.4M+11%reacceleration
ADIA Adia Med$485K+311%expansion
NPHC Nutra Pharma$34K-59%transition
CFOO China Foods Holdings$2-100%contraction

Growth from positive, comparable quarterly revenue as filed; industries are SEC Standard Industrial Classification codes. Data Nov 8, 2026.